(Q46113900)

19 December 2017

title

Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis (English)

1 reference

19 December 2017

1 reference

1 reference

Hanspeter Nick

1

1 reference

19 December 2017

Peter R Allegrini

2

1 reference

19 December 2017

Lucy Fozard

3

1 reference

19 December 2017

Ursula Junker

4

1 reference

19 December 2017

Lisa Rojkjaer

5

1 reference

19 December 2017

Rishard Salie

6

1 reference

19 December 2017

Vera Niederkofler

7

1 reference

19 December 2017

Terrence O'Reilly

8

1 reference

19 December 2017

publication date

20 February 2009

1 reference

19 December 2017

Experimental Biology and Medicine

published in

1 reference

19 December 2017

volume

234

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

492-503

1 reference

19 December 2017

Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice

cites work

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Regulation of iron acquisition and iron distribution in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

The molecular mechanism of hepcidin-mediated ferroportin down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

A mouse model of juvenile hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

Improved R2* measurements in myocardial iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0811-RM-337

21 January 2018

Identifiers

DOI

10.3181/0811-RM-337

1 reference

19 December 2017

1 reference

19 December 2017